Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial.
View/ Open
Date
2018-04Author
Yip, K
Melcher, A
Harrington, K
Illidge, T
Nobes, J
Webster, A
Smith, D
Lorigan, P
Nathan, P
Larkin, J
Type
Journal Article
Metadata
Show full item recordCollections
Research team
Melanoma and Kidney Cancer
Targeted Therapy
Translational Immunotherapy
Language
eng
Date accepted
2017-12-14
License start date
2018-04
Citation
Clinical oncology (Royal College of Radiologists (Great Britain)), 2018, 30 (4), pp. 201 - 203